Log in

La Jolla Pharmaceutical News Headlines (NASDAQ:LJPC)

$7.73
-0.17 (-2.15 %)
(As of 01/19/2020 04:00 PM ET)
Today's Range
$7.66
Now: $7.73
$8.06
50-Day Range
$2.74
MA: $4.22
$8.83
52-Week Range
$2.30
Now: $7.73
$13.90
Volume1.17 million shs
Average Volume1.39 million shs
Market Capitalization$209.95 million
P/E RatioN/A
Dividend YieldN/A
Beta2.05

Headlines

La Jolla Pharmaceutical (NASDAQ LJPC) News Headlines

Source:
DateHeadline
Darryl Wellinghoff Purchases 3,000 Shares of La Jolla Pharmaceutical (NASDAQ:LJPC) StockDarryl Wellinghoff Purchases 3,000 Shares of La Jolla Pharmaceutical (NASDAQ:LJPC) Stock
www.americanbankingnews.com - January 16 at 4:42 PM
Two Small Biotechs See Big Stock Purchases by Their Largest HoldersTwo Small Biotechs See Big Stock Purchases by Their Largest Holders
finance.yahoo.com - January 15 at 9:06 AM
Short Interest in La Jolla Pharmaceutical (NASDAQ:LJPC) Decreases By 8.3%Short Interest in La Jolla Pharmaceutical (NASDAQ:LJPC) Decreases By 8.3%
www.americanbankingnews.com - January 14 at 2:48 PM
La Jolla Pharmaceutical (NASDAQ:LJPC) Director Kevin C. Tang Buys 1,000,000 SharesLa Jolla Pharmaceutical (NASDAQ:LJPC) Director Kevin C. Tang Buys 1,000,000 Shares
www.americanbankingnews.com - January 14 at 2:27 PM
Kevin C. Tang Purchases 2,971,682 Shares of La Jolla Pharmaceutical (NASDAQ:LJPC) StockKevin C. Tang Purchases 2,971,682 Shares of La Jolla Pharmaceutical (NASDAQ:LJPC) Stock
www.americanbankingnews.com - January 13 at 10:16 PM
Jefferies Financial Group Comments on La Jolla Pharmaceuticals FY2019 Earnings (NASDAQ:LJPC)Jefferies Financial Group Comments on La Jolla Pharmaceutical's FY2019 Earnings (NASDAQ:LJPC)
www.americanbankingnews.com - January 13 at 1:18 AM
Brokers Issue Forecasts for La Jolla Pharmaceuticals FY2024 Earnings (NASDAQ:LJPC)Brokers Issue Forecasts for La Jolla Pharmaceutical's FY2024 Earnings (NASDAQ:LJPC)
www.americanbankingnews.com - January 10 at 7:41 AM
La Jolla Pharma sees FY 2019 Giapreza net sales as high as $23MLa Jolla Pharma sees FY 2019 Giapreza net sales as high as $23M
seekingalpha.com - January 9 at 5:04 PM
La Jolla Pharmaceutical Company Announces Preliminary GIAPREZA™ (Angiotensin II) Net Sales for the Three and Twelve Months Ended December 31, 2019La Jolla Pharmaceutical Company Announces Preliminary GIAPREZA™ (Angiotensin II) Net Sales for the Three and Twelve Months Ended December 31, 2019
finance.yahoo.com - January 9 at 5:04 PM
La Jolla Pharmaceutical (NASDAQ:LJPC) Receives Consensus Recommendation of "Hold" from BrokeragesLa Jolla Pharmaceutical (NASDAQ:LJPC) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 31 at 2:58 PM
 Analysts Anticipate La Jolla Pharmaceutical (NASDAQ:LJPC) Will Post Quarterly Sales of $6.47 Million Analysts Anticipate La Jolla Pharmaceutical (NASDAQ:LJPC) Will Post Quarterly Sales of $6.47 Million
www.americanbankingnews.com - December 30 at 2:44 AM
Zacks: Brokerages Anticipate La Jolla Pharmaceutical (NASDAQ:LJPC) to Announce -$1.04 EPSZacks: Brokerages Anticipate La Jolla Pharmaceutical (NASDAQ:LJPC) to Announce -$1.04 EPS
www.americanbankingnews.com - December 28 at 4:18 PM
La Jolla Pharmaceutical (NASDAQ:LJPC) Short Interest UpdateLa Jolla Pharmaceutical (NASDAQ:LJPC) Short Interest Update
www.americanbankingnews.com - December 27 at 8:46 PM
Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy?Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy?
finance.yahoo.com - December 13 at 6:16 PM
BRIEF-La Jolla Pharmaceutical Says Board Approved Restructuring Plan That Reduced HeadcountBRIEF-La Jolla Pharmaceutical Says Board Approved Restructuring Plan That Reduced Headcount
www.msn.com - December 6 at 10:58 PM
BRIEF-La Jolla Pharmaceutical To Discontinue Study Due To Lack Of EfficacyBRIEF-La Jolla Pharmaceutical To Discontinue Study Due To Lack Of Efficacy
www.msn.com - November 25 at 8:33 PM
La Jolla Pharmaceutical Company Announces Management TransitionLa Jolla Pharmaceutical Company Announces Management Transition
finance.yahoo.com - November 25 at 3:32 PM
La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical ResultsLa Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results
finance.yahoo.com - November 25 at 3:32 PM
La Jolla shares fall on CEO departure, clinical trial resultsLa Jolla shares fall on CEO departure, clinical trial results
finance.yahoo.com - November 25 at 3:32 PM
La Jolla Pharmaceutical Company Just Reported And Analysts Have Been Cutting Their EstimatesLa Jolla Pharmaceutical Company Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - November 15 at 2:56 PM
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate ProgressLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Progress
finance.yahoo.com - November 12 at 7:25 PM
La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Misses Revenue EstimatesLa Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 12 at 7:25 PM
Should You Worry About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) CEO Salary Level?Should You Worry About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) CEO Salary Level?
finance.yahoo.com - November 12 at 2:24 PM
Will La Jolla Pharmaceutical (LJPC) Report Negative Q3 Earnings? What You Should KnowWill La Jolla Pharmaceutical (LJPC) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 16 at 2:23 PM
La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)
finance.yahoo.com - August 29 at 11:45 AM
Does La Jolla Pharmaceutical (NASDAQ:LJPC) Have A Healthy Balance Sheet?Does La Jolla Pharmaceutical (NASDAQ:LJPC) Have A Healthy Balance Sheet?
finance.yahoo.com - August 14 at 7:32 PM
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate ProgressLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Progress
finance.yahoo.com - August 1 at 10:45 AM
La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Lags Revenue EstimatesLa Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 1 at 10:45 AM
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of MalariaLa Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of Malaria
finance.yahoo.com - July 23 at 10:02 AM
European advisory group backs La Jollas GiaprezaEuropean advisory group backs La Jolla's Giapreza
seekingalpha.com - June 28 at 8:48 AM
La Jolla Pharmaceutical Company Receives Positive CHMP Opinion for GIAPREZA™ (angiotensin II) for the Treatment of Refractory Hypotension in Adults with Septic or Other Distributive ShockLa Jolla Pharmaceutical Company Receives Positive CHMP Opinion for GIAPREZA™ (angiotensin II) for the Treatment of Refractory Hypotension in Adults with Septic or Other Distributive Shock
finance.yahoo.com - June 28 at 8:48 AM
Despite Reporting Data For A Mid-Stage Study, La Jolla Has Several Other Irons In The Fire For 2019Despite Reporting Data For A Mid-Stage Study, La Jolla Has Several Other Irons In The Fire For 2019
seekingalpha.com - June 19 at 7:21 PM
Implied Volatility Surging for La Jolla Pharmaceutical (LJPC) Stock OptionsImplied Volatility Surging for La Jolla Pharmaceutical (LJPC) Stock Options
finance.yahoo.com - June 11 at 6:51 PM
Heres Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 DaysHere's Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 Days
www.fool.com - June 7 at 4:31 PM
Here's Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 DaysHere's Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 Days
finance.yahoo.com - June 7 at 4:31 PM
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary HemochromatosisLa Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis
finance.yahoo.com - June 6 at 6:39 PM
How La Jolla Pharmaceutical Company (NASDAQ:LJPC) Can Impact Your Portfolio VolatilityHow La Jolla Pharmaceutical Company (NASDAQ:LJPC) Can Impact Your Portfolio Volatility
finance.yahoo.com - May 22 at 6:59 PM
La Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Misses Revenue EstimatesLa Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 6 at 7:19 PM
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseLa Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 2 at 7:41 PM
La Jolla Pharma up 10% premarket on BTD tag for malaria candidateLa Jolla Pharma up 10% premarket on BTD tag for malaria candidate
seekingalpha.com - April 24 at 6:15 PM
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe MalariaLa Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria
finance.yahoo.com - April 24 at 6:15 PM
La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial OfficerLa Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer
finance.yahoo.com - March 11 at 10:37 AM
Does La Jolla Pharmaceutical Company’s (NASDAQ:LJPC) CEO Pay Reflect Performance?Does La Jolla Pharmaceutical Company’s (NASDAQ:LJPC) CEO Pay Reflect Performance?
finance.yahoo.com - March 7 at 6:40 PM
La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare ConferenceLa Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference
finance.yahoo.com - March 7 at 6:40 PM
Do Options Traders Know Something About La Jolla Pharmaceutical (LJPC) Stock We Dont?Do Options Traders Know Something About La Jolla Pharmaceutical (LJPC) Stock We Don't?
www.zacks.com - March 6 at 8:57 AM
Edited Transcript of LJPC earnings conference call or presentation 4-Mar-19 9:30pm GMTEdited Transcript of LJPC earnings conference call or presentation 4-Mar-19 9:30pm GMT
finance.yahoo.com - March 5 at 9:05 AM
La Jolla Pharma Q4 sales up 20%La Jolla Pharma Q4 sales up 20%
seekingalpha.com - March 4 at 7:27 PM
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Highlights Recent Corporate Progress and Key ObjectivesLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Highlights Recent Corporate Progress and Key Objectives
finance.yahoo.com - March 4 at 7:27 PM
La Jolla Pharmaceutical Co (LJPC) Q4 2018 Earnings Conference Call TranscriptLa Jolla Pharmaceutical Co (LJPC) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 4 at 7:27 PM
La Jolla Pharmaceutical Company to Release Fourth Quarter and Full Year 2018 Financial Results on March 4, 2019La Jolla Pharmaceutical Company to Release Fourth Quarter and Full Year 2018 Financial Results on March 4, 2019
finance.yahoo.com - February 25 at 6:44 PM
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel